article thumbnail

So much for pharma earning trust back

World of DTC Marketing

SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided.

article thumbnail

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.

DNA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keeping tabs on Covid-19: Thermo Fisher Scientific antibody test is granted the CE Mark Certification and pharma cargo companies prepare for temperature-controlled vaccine delivery

The Pharma Data

The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.

article thumbnail

Covid comments hurt survivors

World of DTC Marketing

“Were they vaccinated?”, In reviewing social media topics and comments on specific health conditions for clients, I determined that more than 75% of posts contained wrong or inaccurate information. As the CDC extended the mask travel mandate another two weeks, comments on Facebook ranged from the absurd to pure idiocy.

Branding 218
article thumbnail

In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player

Delveinsight

The Government of India in order to contain the spread of novel coronavirus rolled out several guidelines and precautionary measures. Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus.

article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

“This could potentially have a major impact on the efficacy and safety of candidate vaccines and antiviral therapies. The new tool can be used by labs to support their own COVID-19 research projects on their local patient base, and in turn could be used by pharma companies that are developing candidates vaccines and antiviral therapies.

Genetics 136
article thumbnail

Changes to UK Statutory Scheme go ahead despite pharma criticism

Drug Discovery World

This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% Exemptions from payment will be implemented for medicines containing a new active substance, exceptional central procurements and centrally procured vaccines. in 2024, 24% in 2025 and 26.8%